Patrick Twohig

#TLM23 @AmCollegeGastro @AASLDtweets @BeeThoetchai @URMC_DeptMed

🚨 Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic 🚨 📈 >60y, male, Hispanic patients most affected ✅ latest trends >Omicron Article @DDS_Journal: rdcu.be/dpat2 @UNMC_GIHEP @DDWMeeting

📑 Alcohol-associated Hepatitis incidence is 📈 at an alarming rate! Disproportionate 📈 especially among women and individuals of low socioeconomic status‼️🚨 #LiverTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

📑 Increased accuracy in identifying #NAFLD with advanced fibrosis and cirrhosis! ⭐️ Agile 3+ & 4 scores performed superiorly to FIB-4 & LSM by VCTE & maintained good accuracy for diagnosis of adv fibrosis and cirrhosis! #LiverTwitter journals.lww.com/hepcomm/Fullte…

Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trial #LiverTwitter #NAFLD #NASH #semaglutide bit.ly/3NLSSXn

Graduation for @UNMC_GIHEP A sprinkle of 😢 but overwhelming happiness and pride. Congratulations. Go change the 🌎 You’ve got a lot of ❤️ @UNMC_IM #UNMCIM

It’s graduation time 🎓 Celebrating the inaugural HEAL class under the leadership of @CoryRohlfsen Well done Dr Patrick Twohig and Dr Tomoki Sempokuya! #HealthEducatorsAcademicLeaders #UNMCIM

New @AASLDtweets guidance for #HCC should be online at @HEP_Journal soon! Honored to have worked with fantastic multi-D author group, reflecting increasingly complex management. pubmed.ncbi.nlm.nih.gov/37199193/

Top 10 Do & Don’ts in Liver Dz @ebtapper 1️⃣Nutrition (1gm/kg protein / day) 2️⃣Exercise (cirrhosiscare.ca) 3️⃣Pre-op (VOCAL-Penn) 4️⃣PEth 5️⃣Naltrexone 50 mg 6️⃣Carvedilol 12.5 mg daily 7️⃣Educate 8️⃣Symptoms 9️⃣Depression 🔟Mix Lactulose #DDW2023 #GITwitter

Congratulations to Patrick Twohig, MD, MPH on his Fellow Abstract Award! Patrick will present his award-winning abstract at @DDWMeeting May 6-9, 2023. bit.ly/3mRD7Dx #LiverTwitter #DDW2023 @2higMD

Thank you! @AASLDtweets @AASLDFoundation @DDWMeeting

Thank you @AASLDFoundation @AASLDtweets for the abstract 🏆 and poster of distinction🏅Looking fwd to highlighting the prevalence of NAFLD in Turner Syndrome @DDWMeeting !! Grateful for the ongoing support of mentors + co-authors 🤝

Hands-on session at @UNMC_iEXCEL SIM lab for @UNMC_GIHEP fellows. 👏🏻 👏🏻👏🏻 bravo to these superstars 🌟 #Blakemore @UNMC_IM @AmCollegeGastro @AmerGastroAssn @ASGEendoscopy #FutureOfGI #GITwitter

🚨 How to incorporate addiction training into GI/hepatology fellowships 🚨 Check out our editorial to this great article by @lykhaque, citing innovative work by @geneyim, the @AASLDtweets @UNMC_GIHEP @AmCollegeGastro 🔥 off the press in @DDS_Journal rdcu.be/cZGkY

Proud to present our teams study on the benefits of treating alcohol use disorder among hospitalized patients with liver disease: -5-fold ⬇️ risk of 1y ⚰️ -⬇️ age, consult with GI/Hep/psych, brief counseling are all ➕ predictors @AASLDtweets #TLM22 @NIAAAnews

I pushed back on PBC at the Intercept Booth #549 at THE LIVER MEETING®. #PushBackOnPBC #TLMDx ⁦@AASLDtweets⁩ intercept.nextperience.media/short/4ZPdj

Spironolactone as a 💊 for alcohol use disorder? This study in @molpsychiatry found in decreased consumption rates in both mouse and human models 🤯 @DrPsychMD @BeeThoetchai @NIAAAnews

Thank you @AST_info for a highly educational #ASTFellows2022! 👏 ⬆️ Networking, ⬆️ knowledge, and all things #transplant #livertwitter

Recent illicit drug use: Scope or not scope? @2higMD et al found that cancelling endoscopy without considering drug type, dose, and chronicity can unnecessarily delay care and ↑morbidity. Standardized guidelines needed! Read more bit.ly/3C3Qypa #SpringerNature

Recent illicit drug use: Scope or not? We found that cancelling endoscopy without considering drug type, dose, and chronicity can unnecessarily delay care and ↑morbidity. Guidelines needed! @DDS_Journal rdcu.be/cSeev